Quick summary: Elavil: Affected lots may exceed the interim acceptable intake limit for NNORT. Date: 2024-10-18.
Public recall detail
Elavil: Affected lots may exceed the interim acceptable intake limit for NNORT
2024-10-18
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Elavil: Affected lots may exceed the interim acceptable intake limit for NNORT. Date: 2024-10-18.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandAA Pharma Inc., Elavil FCT 10 MG, Elavil FCT 25 MG
ProductElavil
IssueHealth products - Product safety
Recall classType I
IdentificationRA-76359
Affected products
BrandElavil FCT 10 MG
ProductElavil
DIN / NPN / authorizationDIN 00335053
Dosage formTablet
StrengthAmitriptyline Hydrochloride 10 mg
LotTF8594, TF8597, RW8596
BrandElavil FCT 25 MG
ProductElavil
DIN / NPN / authorizationDIN 00335061
Dosage formTablet
StrengthAmitriptyline Hydrochloride 25 mg
LotTF8600
Issue
Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT)
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesAA Pharma Inc. 1165 Creditstone Road Unit #1, Concord, ON L4K 4N7
DistributionAlberta British Columbia Newfoundland and Labrador Ontario Quebec
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-76359
Background{}
CompaniesAA Pharma Inc. 1165 Creditstone Road Unit #1, Concord, ON L4K 4N7
AudiencesGeneral public Healthcare Industry
Source updated2024-10-18
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.